Frazier Healthcare Partners launches Recida Therapeutics to develop therapeutics for serious antibiotic-resistant infections

Image: Recida Therapeutics will develop novel therapeutics for serious antibiotic-resistant infections. Photo: courtesy of Thought Catalog / Unsplash.